S&P 500
5.431,60 -2,14 (-0,04%) Nasdaq
17.688,88 +21,28 (+0,12%) NIKKEI 225
38.106,41 -708,15 (-1,82%) Dólar/Euro
1,0705 -0,0003 (-0,03%) Petróleo Brent
82,33 -0,29 (-0,35%) Bitcoin EUR
61.942,09 +193,82 (+0,31%)
Medpace Holdings, Inc. (MEDP)
Después del cierre:
Medpace Holdings, Inc.
5375 Medpace Way
Cincinnati, OH 45227
United States
513 579 9911
https://www.medpace.com
Sector(es): Healthcare
Sector: Diagnostics & Research
Empleados a tiempo completo: 5800
Ejecutivos clave
| Nombre | Título | Paga | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Dr. August James Troendle M.D. | Chairman & CEO | 1,65M | N/A | 1956 |
| Mr. Jesse J. Geiger BBA, CPA | President | 945,08k | N/A | 1974 |
| Mr. Kevin M. Brady | CFO & Treasurer | 690,48k | 1,64M | 1975 |
| Ms. Susan E. Burwig BSN, MA | Executive Vice President of Operations | 1,12M | 1,47M | 1963 |
| Mr. Stephen P. Ewald J.D. | Chief Compliance Officer, General Counsel & Corporate Secretary | 914,64k | 3,2M | 1969 |
| Brandon Ebken | Chief Information Officer | N/A | N/A | N/A |
| Ms. Lauren Morris | Associate Director of Investors Relations | N/A | N/A | N/A |
| Mr. Todd Meyers | Vice President of Business Development & Marketing | N/A | N/A | N/A |
| John T. Wynne MBA | Senior Vice President of Commercial Operations & Clinical Pharmacology Unit | N/A | N/A | N/A |
| Mr. Reinilde Heyrman M.D. | Chief Medical Officer of Medical Department | N/A | N/A | 1961 |
Descripción
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Gobierno corporativo
El ISS Governance QualityScore de Medpace Holdings, Inc., a día 1 de junio de 2024, es 7. Las puntuaciones base son Auditoría: 5; Tablero: 9; Derechos de los accionistas: 7; Compensación: 4.
